i2o Therapeutics

Allston, United States

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

$46.0M raised

Aug 2023

Series A

Biotechnology Health Care Therapeutics

Top Investors

Touchdown VenturesJDRF T1D FundSanofi VenturesViva BioInnovator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about i2o Therapeutics

How much funding has i2o Therapeutics raised?

i2o Therapeutics has raised $46.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.

Who are i2o Therapeutics's investors?

i2o Therapeutics's investors include Touchdown Ventures, JDRF T1D Fund, Sanofi Ventures, Viva BioInnovator.

Where is i2o Therapeutics headquartered?

i2o Therapeutics is headquartered in Allston, United States.

What does i2o Therapeutics do?

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

What stage is i2o Therapeutics at?

i2o Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 28, 2023.

MLA

"i2o Therapeutics — Funding & Investors." VCBacked, August 28, 2023, https://www.vcbacked.co/company/i2o-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2023). i2o Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/i2o-therapeutics

Wikipedia (cite web)

{{cite web |title=i2o Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/i2o-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 28, 2023.

Similar Companies in Biotechnology